Style
Deep ValueTurnover
Orientation
Concentrated long-term| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Arcus Biosciences Inc.(RCUS) | 31,424,760 | $968.8M | 58.76% |
| 2 | Lakefront Biotherapeutics(GLPG) | 16,707,477 | $500.2M | 30.34% |
| 3 | Assembly Biosciences Inc.(ASMB) | 4,977,089 | $136.8M | 8.30% |
| 4 | Kyverna Therapeutics Inc.(KYTX) | 4,126,119 | $36.8M | 2.23% |
| 5 | Xilio Therapeutics Inc.(XLO) | 650,389 | $6.2M | 0.38% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 100% | 100% | 0% |
Quarter-over-quarter weight changes by market cap
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Mid Cap | 92.16% |
| 89.1% |
| -3.06% |
| Small Cap | 7.84% | 10.9% | +3.06% |
Quarter-over-quarter position changes